EU plans to scrap Valneva’s COVID vaccine deal

Circuit model may explain how deep brain stimulation treats Parkinson’s disease symptoms
16 May 2022
Immunotherapy may play role in treating nonmetastatic gastroesophageal cancer
16 May 2022

EU plans to scrap Valneva’s COVID vaccine deal

The European Commission intends to terminate an agreement to buy the COVID vaccine of French-Austria drug maker Valneva as the shot has yet to receive marketing authorisation, the company said Monday.

Comments are closed.